person · Reporting owner
Mazur-Hofsaess Katarzyna
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Pres., Eur., M. East & Afr. | May 22, 2018 | May 23, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date May 22, 2018 · Filed May 23, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,682 |
Ending reported balance
After 2018-05-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-05-22 · Exercise / conversion · Acquired 8,765 · Balance 25,447 Row 2 · 2018-05-22 · Sale · Disposed 8,765 · Balance 16,682 F1: Represents the sale of 8,765 shares in multiple transactions ranging in price from $113.30 to $114.14 per share, resulting in a weighted average sale price of $113.6104. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.15 · Expires 2023-03-18 | Direct | 0 |
Reported balance
After 2018-05-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-05-22 · Exercise / conversion · Disposed 8,765 · Balance 0 F2: Vested annually over four years in increments of 25% each year, commencing on March 18, 2014. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the sale of 8,765 shares in multiple transactions ranging in price from $113.30 to $114.14 per share, resulting in a weighted average sale price of $113.6104. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F2: Vested annually over four years in increments of 25% each year, commencing on March 18, 2014.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2018 Filed May 23, 2018 21:05 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,765 | $0.00 Strike: $73.15 | $0.00 |
DisclosureSEC source: 0000911916-18-000127 · edgar.xml · derivative · entry 3 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,765 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on March 18, 2014. Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:05 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 8,765 | $113.61 | $995,795.16 |
DisclosureSEC source: 0000911916-18-000127 · edgar.xml · nonDerivative · entry 2 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,682 F1 · price: Represents the sale of 8,765 shares in multiple transactions ranging in price from $113.30 to $114.14 per share, resulting in a weighted average sale price of $113.6104. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:05 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 8,765 | $73.15 | $641,159.75 |
DisclosureSEC source: 0000911916-18-000127 · edgar.xml · nonDerivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 27,780 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000069 · edgar.xml · derivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,780 Underlying: Common Stock · 27,780 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:36 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 33,325 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000043 · edgar.xml · derivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,325 Underlying: Common Stock · 33,325 shares Expires 2028-02-20 Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 21:00 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 29,072 | $0.00 Strike: $121.88 | $0.00 |
DisclosureSEC source: 0000911916-17-000127 · edgar.xml · derivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,072 Underlying: Common Stock · 29,072 shares Expires 2027-03-21 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 19:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 4,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000114 · edgar.xml · derivative · entry 2 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,685 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: The earned RSUs vested on March 17, 2017. F2 · derivative.expiration_date: The earned RSUs vested on March 17, 2017. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 19:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000114 · edgar.xml · nonDerivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 19:51 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 4,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000056 · edgar.xml · derivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,685 Underlying: Common Stock · 4,685 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,685 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017. F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017. F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,685 RSUs. F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 4,685 RSUs. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,963 | $0.00 Strike: $94.34 | $0.00 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · derivative · entry 9 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,962 Underlying: Common Stock · 12,963 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 17, 2015. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,530 | $0.00 Strike: $73.15 | $0.00 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · derivative · entry 8 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,765 Underlying: Common Stock · 17,530 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 8,765 of the options vested on each of March 18, 2014, 2015 and 2016; the remaining 8,765 of the options are scheduled to vest on March 18, 2017. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,312 | $0.00 Strike: $64.13 | $0.00 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · derivative · entry 7 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,312 shares Expires 2022-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 5,657 of the options vested on March 19, 2013 and 5,656 of the options vested on each of March 19, 2014, 2015, and 2016. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,390 | $0.00 Strike: $60.01 | $0.00 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · derivative · entry 6 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,390 shares Expires 2021-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 2,390 options vested on each of March 16, 2012, 2013, 2014, and 2015. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 44,195 | $118.00 | $5,215,010.00 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 5 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,997 Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 12,963 | $94.34 | $1,222,929.42 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 4 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 17,530 | $73.15 | $1,282,319.50 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 3 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 11,312 | $64.13 | $725,438.56 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 2 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,390 | $60.01 | $143,423.90 |
DisclosureSEC source: 0000911916-17-000042 · edgar.xml · nonDerivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.